1). Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998. 62:1094–156.
Article
2). Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther. 2008. 6:509–21.
3). Waites KB., Talkington DE. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004. 17:697–728.
4). Chiang WC., Teoh OH., Chong CY., Goh A., Tang JP., Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology. 2007. 12:254–61.
Article
5). Al Rashed A. Role of Mycoplasma pneumoniae in acute respiratory-tract infections in Saudi paediatric patients. Ann Trop Med Parasitol. 1998. 92:595–601.
6). Kurashi NY., Al-Hamdan A., Ibrahim EM., Al-Idrissi HY., Al-Bayari TH. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax. 1992. 47:115–8.
Article
7). Moule JH., Caul EO., Wreghitt TG. The specific IgM response to Mycoplasma pneumoniae infection: interpretation and application to early diagnosis. Epidemiol Infect. 1987. 99:685–92.
8). Lind K., Benzon MW., Jensen JS., Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946~1995. Eur J Epidemiol. 1997. 13:581–6.
9). Gray GC., Rodier GR., Matras-Maslin VC., Honein MA., Ismail EA., Botros BA, et al. Serologic evidence of respiratory and rickettsial infections among Somali refugees. Am J Trop Med Hyg. 1995. 52:349–53.
Article
10). Kleemola SR., Karjalainen JE., Räty RK. Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test. J Infect Dis. 1990. 162:70–5.
11). Chay OM., Hiew J., Tan CK., Foo AL., Lim KW., Cheng HK. Etiology of acute severe lower respiratory tract infection in hospital-based patients. Southeast Asian J Trop Med Public Health. 1992. 23:293–6.
12). Foy HM. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979. 139:681–7.
13). Lieberman D., Porath A. Seasonal variation in community-acquired pneumonia. Eur Respir J. 1996. 9:2630–4.
Article
14). Ghosh K., Clements GB. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986~1991. J Infect. 1992. 25:221–7.
15). Saikku P., Ruutu P., Leinonen M., Kleemola M., Paladin F., Tupsi TE. Mycoplasma pneumoniae and Chlamydia trachomatis in acute lower respiratory infections in Filipino children. Am J Trop Med Hyg. 1993. 49:88–92.
16). Sung RY., Cheng AF., Chan RC., Tam JS., Oppenheimer SJ. Epidemiology and etiology of pneumonia in children in Hong Kong. Clin Infect Dis. 1993. 17:894–6.
Article
17). Vikerfors T., Brodin G., Grandien M., Hirschberg L., Krook A., Pettersson CA. Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: a clinical evaluation. Scand J Infect Dis. 1988. 20:601–10.
18). Lind K., Bentzon MW. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect. 1991. 107:189–99.
19). Dorigo-Zetsma JW., Zaat SA., Wertheim-van Dillen PM., Spanjaard L., Rijintjes J., van Waveren G, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol. 1999. 37:14–7.
20). Kenny GE., Cartwright FD. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Antimicrob Agents Chemother. 1991. 35:587–9.
21). Waites KB., Duffy LB., Schmid T., Crabb D., Pate MS., Cassell GH. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 1991. 35:1181–5.